Publicaciones (86) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice

    Pharmacological Research, Vol. 169

  2. A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748

  3. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

    Nature, Vol. 592, Núm. 7856, pp. 799-803

  4. Addiction and the kynurenine pathway: A new dancing couple?

    Pharmacology and Therapeutics, Vol. 223

  5. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

    European Journal of Pharmacology, Vol. 895

  6. Analysis of molecular networks in the cerebellum in chronic schizophrenia: Modulation by early postnatal life stressors in murine models

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  7. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

    JAMA Neurology, Vol. 78, Núm. 10, pp. 1236-1248

  8. Autoradiographic Visualization of G Protein-Coupled Receptors in Brain

    Neuromethods (Humana Press Inc.), pp. 161-174

  9. Bip heterozigosity aggravates pathological deterioration in experimental amyotrophic lateral sclerosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  10. COVID-19 as a unique opportunity to unravel the link between prenatal maternal infection, brain development and neuropsychiatric disorders in offspring

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 1-3

  11. Cancer Treatment: Preclinical & Clinical

    Journal of the National Cancer Institute - Monographs, Vol. 2021, Núm. 58, pp. 107-113

  12. Cannabinoid Cancer Biology and Prevention

    Journal of the National Cancer Institute - Monographs, Vol. 2021, Núm. 58, pp. 99-106

  13. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  14. Cdse quantum dots in human models derived from als patients: Characterization, nuclear penetration studies and multiplexing

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-15

  15. Central activation of alpha7 nicotinic signaling attenuates lps-induced neuroinflammation and sickness behavior in adult but not in aged animals

    Molecules, Vol. 26, Núm. 8

  16. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  17. Chapter 2: Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System

    RSC Drug Discovery Series (Royal Society of Chemistry), pp. 10-47

  18. Chemistry for the Identification of Therapeutic Targets: Recent Advances and Future Directions

    European Journal of Organic Chemistry, Vol. 2021, Núm. 9, pp. 1307-1320

  19. Childhood trauma determines different clinical and biological manifestations in patients with eating disorders

    Eating and Weight Disorders, Vol. 26, Núm. 3, pp. 847-857

  20. Circadian Biology and Stroke

    Stroke, Vol. 52, Núm. 6, pp. 2180-2190